Overview

Buprenorphine and Integrated HIV Care Evaluation

Status:
Unknown status
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the feasibility, cost and effectiveness of interventions designed to integrate buprenorphine treatment for opioid dependence into HIV primary care in ten HIV care centers in the U.S.
Phase:
Phase 4
Details
Lead Sponsor:
The New York Academy of Medicine
Collaborators:
Brown University
CORE Center, Cook County Bureau of Health Services
El Rio Santa Cruz Neighborhood Health Center
Health Resources and Services Administration (HRSA)
Johns Hopkins University
Montefiore Medical Center
Oregon Health and Science University
Organization to Achieve Solutions in Substance Abuse (OASIS)
University of California, San Francisco
University of Miami
Yale University
Treatments:
Analgesics, Opioid
Buprenorphine